Risk factors for Clostridium difficile infection (Q34475773)

2 August 2017

0 references

1 reference

title

Risk factors for Clostridium difficile infection (English)

1 reference

2 August 2017

main subject

Clostridium difficile

0 references

author name string

Bignardi GE

series ordinal

1 reference

2 August 2017

publication date

1 September 1998

1 reference

Journal of Hospital Infection

2 August 2017

published in

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

1-15

1 reference

Antibiotic-associated pseudomembranous colitis: an epidemiologic investigation of a cluster of cases

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Evaluation of mezlocillin in elective gastrointestinal surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Diagnosis and epidemiology of Clostridium difficile enterocolitis in Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Clostridium difficile. Colonization and toxin production in a cohort of patients with malignant hematologic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Prospective study comparing imipenem-cilastatin with clindamycin and gentamicin for the treatment of serious surgical infections

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Clostridium difficile infection in patients with haematological malignant disease. Risk factors, faecal toxins and pathogenic strains

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Third generation cephalosporins as a risk factor for Clostridium difficile-associated disease: a four-year survey in a general hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Extended spectrum cephalosporins and Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Nosocomial acquisition of Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Risk factors for Clostridium difficile toxin-associated diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Cefamandole versus cefonicid prophylaxis in cardiovascular surgery: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Postantibiotic colonization with Clostridium difficile in nursing home patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Prospective study of Clostridium difficile intestinal colonization and disease following single-dose antibiotic prophylaxis in surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Risk factors for Clostridium difficile-associated diarrhoea in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

The prevalence and nosocomial acquisition of Clostridium difficile in elderly hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Infection due to Clostridium difficile among elderly residents of a long-term-care facility

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Clostridium difficile colonization in residents of long-term care facilities: prevalence and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Epidemiology of community-acquired Clostridium difficile-associated diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Drug risk factors associated with a sustained outbreak of Clostridium difficile diarrhea in a teaching hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Epidemic Clostridium difficile-associated diarrhea: role of second- and third-generation cephalosporins.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

[Incidence and importance of Clostridium difficile in patients treated with antibacterial therapy or perioperative preventive cefoxitin administration]

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Clostridium difficile colonization and diarrhea at a tertiary care hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Clostridium difficile colitis: an increasing hospital-acquired illness

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Surgical Antibiotic Prophylaxis and Clostridium difficile Toxin Positivity

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Clostridium difficile-associated diarrhoea and length of hospital stay

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Increased length of hospital stay due to Clostridium difficile associated diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Investigation and management of Clostridium difficile colonisation in a paediatric oncology unit

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Use of pulsed-field gel electrophoresis for investigation of an outbreak of Clostridium difficile infection among geriatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Incidence of diarrhea and Clostridium difficile toxin in stools from hospitalized patients receiving clindamycin, beta-lactams, or nonantibiotic medications

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Risk factors for Clostridium difficile cytotoxin-positive diarrhea after control for horizontal transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Risk factors for Clostridium difficile stool cytotoxin b among critically ill patients: role of sucralfate

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Clostridium difficile colitis: an efficient clinical approach to diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Epidemiology of infectious and iatrogenic nosocomial diarrhea in a cohort of general medicine patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

Severe Clostridium difficile colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990019-6

7 January 2021

10.1016/S0195-6701(98)90019-6

Identifiers

DOI

1 reference

2 August 2017

1 reference